Cetirizine dihydrochloride
The active substance of Amertil is cetirizine dihydrochloride.
Amertil is an antiallergic medicine.
Amertil is indicated for adults and children aged 6 years and above:
Before taking Amertil, discuss with your doctor:
No significant clinically relevant interactions (mutual effects) have been observed between alcohol
(at a concentration of 0.5 per mille (g/l) in the blood, corresponding to a concentration after drinking one glass of wine)
and cetirizine administered at the recommended doses. However, there are no data on the safety
of concomitant use of higher doses of cetirizine and alcohol. Therefore, as with other antihistamine medicines, it is recommended to avoid taking Amertil with alcohol.
If you are scheduled to undergo skin allergy tests, you should ask your doctor whether you should stop taking Amertil a few days before the test. Amertil may affect the results of skin allergy tests.
Amertil coated tablets are not recommended for children under 6 years of age, as this pharmaceutical form does not allow for appropriate dose adjustment. It is recommended to use a pharmaceutical form intended for children (e.g., oral drops or oral solution).
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take.
Studies with cetirizine indicate that interactions with other medicines are not expected.
Food does not affect the absorption of Amertil.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Amertil should be avoided in pregnant women. Accidental intake of the medicine by a pregnant woman should not have a harmful effect on the fetus. However, the medicine should only be used if necessary and in agreement with your doctor.
Cetirizine passes into breast milk. Therefore, you should not take Amertil during breastfeeding.
Clinical studies have not shown any impairment of reaction time, and ability to drive or operate machinery after administration of cetirizine at the recommended dose.
If you plan to drive a vehicle, perform potentially hazardous activities, or operate machinery after taking Amertil, you should carefully observe your body's reaction to the medicine. Do not take a higher dose than recommended.
If you have been told that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Swallow the tablets with a glass of liquid.
The tablet can be divided into two equal doses.
10 mg (1 tablet) once daily
5 mg twice daily (half a tablet twice daily)
In patients with moderate renal impairment, a dose of 5 mg once daily is recommended.
If you have severe kidney disease, consult your doctor, who will adjust the dose accordingly.
If your child has severe kidney disease, consult your doctor, who will adjust the dose according to your child's needs.
If you feel that the effect of Amertil is too strong or too weak, consult your doctor.
The duration of treatment depends on the type, duration, and course of the disease, and is determined by your doctor.
If you have taken more than the recommended dose of Amertil, contact your doctor immediately. Your doctor will decide what measures to take.
After an overdose, the following side effects may occur with increased intensity: disorientation, diarrhea, dizziness, fatigue, headache, malaise, dilated pupils, itching, restlessness, sedation, somnolence, stupor, increased heart rate, tremor, and urinary retention.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Amertil can cause side effects, although not everybody gets them.
Frequency not known(frequency cannot be estimated from the available data):
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in a temperature below 25°C.
Store in the original package to protect from light and moisture.
Do not use this medicine after the expiry date stated on the carton after "EXP:" and on the blister after "EXP:".
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
White, round, biconvex coated tablets, with a score line on one side to facilitate breaking.
The pack contains 20, 30, or 60 coated tablets.
Not all pack sizes may be marketed.
Biofarm Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
tel. +48 61 66 51 500
faks: +48 61 66 51 505
biofarm@biofarm.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.